2021 annual financial data
Relmada Therapeutics 2021 Operating cash flow margin
Relmada Therapeutics 2021 operating cash flow margin with verified reported val…
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -125,703,492 USD and net income was -125,751,809 USD.
Operating cash flow was -91,873,395 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -125,703,492 USD
- Net income
- -125,751,809 USD
- Operating cash flow
- -91,873,395 USD